Workshop Interceptor - WG6: Socio-economics, impact and ethics (September 22nd 2023)

You are here

The aim of the workpackage on socio-economic and ethical impact (WP6) is to build a network of Centers having the expertise, facilities and availability and a framework to conduct Health Technology Assessments (HTA) of new preventive strategies for OPMD (such as early detection programs, or biomarkers) for their own country to support implementation and reimbursement.

The aim of the workshop was to construct a basis for a HTA framework concerning early detection for OPMD. Four speakers were invited representing four stakeholder perspectives: HTA research, ethical research, policy maker and a patient organization. Subsequently, a roundtable discussion was held concerning the basis for HTA framework “What are the important determinants to include in the framework from the different stakeholder perspectives?”. Finally, potential short term scientific meetings (STSMs) were discussed and proposed for the coming WP activities.

Table with participants (Face-to-face and Online)

Name

Title

Country

Institution

ITC

Expertise

Gülcihan Gülseren

Dr

Turkey

Konya Food and Agriculture University

yes

PhD

Aleksandar Čelebić

Dr

Montenegro

Clinical Center of Montenegro

yes

Oncologist

Anika Vishwakarma

Mrs

Ireland

Technology University Dublin

no

Dentistry

Rui Amaral Mendes

Prof

Portugal

CINTESIS/FMUP

yes

MD

Antonella Cardone

Mrs

Belgium

Cancer Patients Europe

no

Patient organization

Amarda Gica

Mrs

Albania

Faculty of Medical Technical Science

yes

Clinician

Muhammet Karaman

Dr

Turkey

Kilis 7 Aralık University

yes

PhD

Pierre Saintigny

Dr

France

Centre Léon Bérard

no

MD, PhD

Pascal Ducournau

Prof

France

Université de Franche-Comté

no

Sociologist

Ruben Sakowsky

Dr

Germany

University Medical Center Göttingen

no

Ethicist

Brenda Bogaert

Dr

Switzerland

CHUV/UNIL

no

Ethicist

Valesca Retel

Prof

Netherlands

Netherlands Cancer Institute

no

HTA

Lionel Perrier

Dr

France

Centre Léon Bérard

no

HTA

Marine Benaissa

Dr

France

Centre Léon Bérard

no

PhD

Wim van Harten

Prof

Netherlands

Netherlands Cancer Institute

no

policy

Amina Huseinbegovic

Prof

Bosnia Herzegovina

University of Sarajevo Faculty of Dentistry with Clinics

yes

Preventive dentistry and public oral health

Kathy Jaworski

Dr

Luxembourg

Institut National du Cancer (INC)

no

Policy

Martina Coppini

Dr

Italy

University of Palermo

no

PhD

Kristina Mitic

Prof

North Macedonia

Faculty of Dentistry

yes

Clinician

Akhilanand Chaurasia

Prof

India

King George's Medical University

no

PhD

Sílvia Fernandes

Prof

Portugal

Escola Superior de Saúde do Politécnico do Porto

yes

Pathological, Cytological and Thanatological Anatomy

Daniela Elena Costea

Prof

Norway

University of Bergen

no

Pathology

Carina Ladeira

Dr

Portugal

Escola Superior de Tecnologia da Saúde de Lisboa - Instituto Politécnico de Lisboa

yes

PhD

Banu Sipahi

Dr

Turkey

Tarsus University

yes

microeconomics, econometrics and health economics

Dimitris Tatsis

Mr

Greece

Aristotle University of Thessaloniki

yes

MD, DDS

Emanuela Boštjančič

Dr

Slovenia

Institute of Pathology

yes

PhD

Patryk Niewinski

Dr

Poland

Poznan University of Medical Sciences

yes

MD

Gökhan Doğukan Akarsu

Dr

Turkey

Vocational School Of Health Services

yes

PhD

Zoltan Takacsi-Nagy

Dr

Hungary 

Országos Onkológiai Intézet

yes

MD

Related documents: 
AttachmentSize
PDF icon Agenda434.61 KB

Keep up with the latest news,
subscribe our Newsletter

linkedin

linkedin   x  

Project information

INTERCEPTOR aims to address the challenge of generating innovative and actionable pathways by engaging with the ‘critical practice’ dimensions of transformation.

A ‘critical practice’ approach explores transformation processes in practice across different dimensions which include research, policy, business, community and individual practices.

Action Contacts

Prof. Pierre Saintigny
Action Chair
+33(0)4 69 85 60 97
pierre.saintigny@lyon.unicancer.fr

Prof. Senada Koljenovic
Action Vice Chair
+31652090524
senada.koljenovic@uza.be

COST Contacts

Dr Rosella Magli
Science Officer
+3225333833
Rossella.Magli@cost.eu

Ms Carmencita Malimban
Administrative Officer
+3225333842
carmencita.malimban@cost.eu

COST    EN FUNDED

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. Our Actions help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation. www.cost.eu